Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Mirkin

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Obstetrics and Gynecology|June 12, 2018
A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled TrialRogerio A Lobo, David F Archer, Risa Kagan, et al.
Contraception|November 10, 2011
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderUriel Halbreich, Ellen W Freeman, Andrea J Rapkin, et al.
Bone|April 29, 2015
The effects of bazedoxifene on bone structural strength evaluated by hip structure analysisThomas J Beck, Thomas Fuerst, Kenneth W Gaither, et al.
Menopause (New York, N.Y.)|February 11, 2015
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fractureSantiago Palacios, Stuart L Silverman, Tobie J de Villiers, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Obstetrics and Gynecology|June 12, 2018
A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled TrialRogerio A Lobo, David F Archer, Risa Kagan, et al.
Contraception|November 10, 2011
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorderUriel Halbreich, Ellen W Freeman, Andrea J Rapkin, et al.
Bone|April 29, 2015
The effects of bazedoxifene on bone structural strength evaluated by hip structure analysisThomas J Beck, Thomas Fuerst, Kenneth W Gaither, et al.
Menopause (New York, N.Y.)|February 11, 2015
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fractureSantiago Palacios, Stuart L Silverman, Tobie J de Villiers, et al.
Pageof 11